Trial Profile
A study of peginterferon (alfa-2a or alfa-2b) in HIV/HBV coinfected patients treated with tenofovir/emtricitabine-containing regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Emtricitabine; Tenofovir
- Indications Hepatitis B; HIV infections
- Focus Therapeutic Use
- 16 Dec 2015 New trial record